Skip to main content

Advertisement

SpringerLink
Log in

Current Views on the Relationship between Fibromyalgia and Mental Disorders

  • Published:
Neuroscience and Behavioral Physiology Aims and scope Submit manuscript

Fibromyalgia (FM) is a pain syndrome with a high burden of morbidity and poorly understood etiology and pathogenesis. Significant quantities of data have now been accumulated indicating that FM has close and bidirectional associations with mental disorders and is also associated with certain personality characteristics which contribute to the severity of key somatic symptoms and generally influence the prognosis of the disease. This review presents results from current epidemiological and neurobiological studies, discusses the multi-level relationship between FM and mental disorders, and provides a brief review of approaches to the treatment of comorbidities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators, “Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017,” Lancet, 392, No. 10159, 1789–1858 (2018), https://doi.org/10.1016/S0140-6736(18)32279-7.

  2. Lage-Hansen, P. R., Chrysidis, S., Amris, K., et al., “Prevalence of survey-based criteria for fibromyalgia and impact on hospital burden: a 7 year follow-up study from an outpatient clinic,” Scand. J. Rheumatol., 52, No. 5, 539–548 (2023), https://doi.org/10.1080/03009742.2022.2145703.

    Article  CAS  PubMed  Google Scholar 

  3. Chang, M. H., Hsu, J. W., Huang, K. L., et al., “Bidirectional association between depression and fibromyalgia syndrome: A nationwide longitudinal study,” J. Pain, 16, No. 9, 895–902 (2015), https://doi.org/10.1016/J.JPAIN.2015.06.004.

    Article  PubMed  Google Scholar 

  4. Creed, F., “New research on medically unexplained symptom – much remains to be done before DSM V and ICD-10 can provide a satisfactory new classification,” J. Psychosom. Res., 66, No. 5, 359–361 (2009), https://doi.org/10.1016/J.JPSYCHORES.2009.02.005.

    Article  PubMed  Google Scholar 

  5. American Psychiatric Association, “Highlights of Changes from DSM-IV to DSM-5,” Focus, 11, No. 4, 525–527 (2013), https://doi.org/10.1176/appi.focus.11.4.525.

    Article  Google Scholar 

  6. Wolfe, F., Clauw, D. J., Fitzcharles, M. A., et al., “2016 revisions to the 2010/2011 fibromyalgia diagnostic criteria,” Semin. Arthritis Rheum., 46, No. 3, 319–329 (2016), https://doi.org/10.1016/J.SEMARTHRIT.2016.08.012.

    Article  PubMed  Google Scholar 

  7. Arnold, L. M., Bennett, R. M., Crofford, L. J., et al., “AAPT diagnostic criteria for fibromyalgia,” J. Pain, 20, No. 6, 611–628 (2019), https://doi.org/10.1016/J.JPAIN.2018.10.008.

    Article  PubMed  Google Scholar 

  8. Salaffi, F., Di Carlo, M., Farah, S., et al., “Diagnosis of fibromyalgia: comparison of the 2011/2016 ACR and AAPT criteria and validation of the modified Fibromyalgia Assessment Status,” Rheumatology, 59, No. 10, 3042–3049 (2020), https://doi.org/10.1093/RHEUMATOLOGY/KEAA061.

    Article  PubMed  Google Scholar 

  9. Kang, J. H., Choi, S. E., Xu, H., et al., “Comparison of the AAPT fibromyalgia diagnostic criteria and modified FAS criteria with existing ACR criteria for fibromyalgia in Korean patients,” Rheumatol. Ther., 8, No. 2, 1003–1014 (2021), https://doi.org/10.1007/S40744-021-00318-8.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Shapoval, I. and Stanislavchuk, M., “Comparative characteristics of ACR 1990, mACR 2010, ACR 2016 and AAPT 2019 criteria for diagnosing fibromyalgia in patients with ankylosing spondylitis,” Rheumatol. Int., 43, No. 1, 69–77 (2023), https://doi.org/10.1007/S00296-022-05168-3.

    Article  CAS  PubMed  Google Scholar 

  11. World Health Organization, International Statistical Classification of Diseases and Related Health Problems (2004), acc. June 5, 2023.

  12. World Health Organization, International Statistical Classification of Diseases and Related Health Problems, 11th ed., acc. June 5, 2023.

  13. Choy, E., Perrot, S., Leon, T., et al., “A patient survey of the impact of fibromyalgia and the journey to diagnosis,” BMC Health Serv. Res., 10, 102 (2010), https://doi.org/10.1186/1472-6963-10-102.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Lacasse, A., Bourgault, P., and Choinière, M., “Fibromyalgia-related costs and loss of productivity: a substantial societal burden,” BMC Musculoskelet. Disord., 17, 168 (2016), https://doi.org/10.1186/S12891-016-1027-6.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Haliloglu, S., Carlioglu, A., Akdeniz, D., et al., “Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity,” Rheumatol. Int., 34, No. 9, 1275–1280 (2014), https://doi.org/10.1007/S00296-014-2972-8.

    Article  CAS  PubMed  Google Scholar 

  16. Melikova, N. A., Filatova, E. G., and Lila, A. M., “Fibromyalgia in rheumatoid arthritis: features of pain, impact on disease activity, and quality of life of patients,” Sovrem. Revmatol., 16, No. 1, 32–37 (2022), https://doi.org/10.14412/1996-7012-2022-1-32-37.

  17. Kleykamp, B. A., Ferguson, M. C., McNicol, E., et al., “The Prevalence of psychiatric and chronic pain comorbidities in fibromyalgia: an ACTTION systematic review,” Semin. Arthritis Rheum., 51, No. 1, 166–174 (2021), 10.1016/J. SEMARTHRIT.2020.10.006.

    Article  PubMed  Google Scholar 

  18. World Health Organization, Depression and Other Common Mental Disorders: Global Health Estimates (2017), acc. June 5, 2023.

  19. Marrie, R. A., Hitchon, C. A., Walld, R., et al., “Increased burden of psychiatric disorders in rheumatoid arthritis,” Arthritis Care Res., 70, No. 7, 970–978 (2018), https://doi.org/10.1002/ACR.23539.

    Article  Google Scholar 

  20. Klaus, K., Fischer, S., Doerr, J. M., et al., “Classifying fibromyalgia syndrome as a mental disorder? – An ambulatory assessment study,” Int. J. Behav. Med., 24, No. 2, 230–238 (2017), https://doi.org/10.1007/S12529-016-9603-6.

    Article  PubMed  Google Scholar 

  21. Heidari, F., Afshari, M., and Moosazadeh, M., “Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis,” Rheumatol. Int., 37, No. 9, 1527–1539 (2017), https://doi.org/10.1007/S00296-017-3725-2.

    Article  PubMed  Google Scholar 

  22. Queiroz, L. P., “Worldwide epidemiology of fibromyalgia,” Curr. Pain Headache Rep., 17, No. 8, 356 (2013), https://doi.org/10.1007/S11916-013-0356-5.

  23. Spaeth, M., “Epidemiology, costs, and the economic burden of fibromyalgia,” Arthritis Res. Ther. 11, No. 3, 117 (2009), https://doi.org/10.1186/AR2715.

  24. Branco, J. C., Bannwarth, B., Failde, I., et al., “Prevalence of fibromyalgia: a survey in five European countries,” Semin. Arthritis Rheum., 39, No. 6, 448–453 (2010), https://doi.org/10.1016/J.SEMARTHRIT.2008.12.003.

    Article  PubMed  Google Scholar 

  25. Arnold, L. M., Clauw, D. J., and McCarberg, B. H., “Improving the recognition and diagnosis of fibromyalgia,” Mayo Clin. Proc., 86, No. 5, 457–464 (2011), https://doi.org/10.4065/MCP.2010.0738.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Teplyakova, O. V., Popov, A. A., Volkova, L. I., and Sarapulova, A. V., “Fibromyalgia: clinical picture and disease variants,” Sovrem. Revmatol. 14, No. 2, 45–51 (2020), https://doi.org/10.14412/1996-7012-2020-2-45-51.

  27. Seelman, K. L., Young, S. R., Tesene, M., et al., “A comparison of health disparities among transgender adults in Colorado (USA) by race and income,” Int. J. Transgend., 18, No. 2, 199–214 (2017), https://doi.org/10.1080/15532739.2016.1252300.

    Article  PubMed  Google Scholar 

  28. Levit, D., Yaish, I., Shtrozberg, S., et al., “Pain and transition: evaluating fibromyalgia in transgender individuals,” Clin. Exp. Rheumatol., 39, No. 3, Supplement 130, 27–32 (2021).

  29. Athnaiel, O., Cantillo, S., Paredes, S., and Knezevic, N. N., “The role of sex hormones in pain-related conditions,” Int. J. Mol. Sci., 24, No. 3, 1866 (2023), https://doi.org/10.3390/IJMS24031866.

  30. Coles, M. L., Weissmann, R., and Uziel, Y., “Juvenile primary fibromyalgia syndrome: Epidemiology, etiology, pathogenesis, clinical manifestations and diagnosis,” Pediatr. Rheumatol., 19, No. 1, 1–10 (2021), https://doi.org/10.1186/S12969-021-00493-6.

    Article  Google Scholar 

  31. Creed, F., Tomenson, B., Chew-Graham, C., et al., “The associated features of multiple somatic symptom complexes,” J. Psychosom. Res., 112, 1–8 (2018), 10.1016/J. JPSYCHORES.2018.06.007.

    Article  PubMed  Google Scholar 

  32. Goesling, J., Lin, L. A., and Clauw, D. J., “Psychiatry and pain management: at the intersection of chronic pain and mental health,” Curr. Psychiatry Rep., 20, No. 2, 12 (2018), https://doi.org/10.1007/S11920-018-0872-4.

  33. Satghare, P., Abdin E Bin, Hombali, A., et al., “Chronic pain: Among tertiary care psychiatric out-patients in Singapore – prevalence and associations with psychiatric disorders,” Pain Res. Manag., 2022, 1825132 (2022), https://doi.org/10.1155/2022/1825132.

  34. Svyatskaya, E. A., Bryzgalova, J. E., Kustov, G. V., et al., “Chronic pain and fibromyalgia: problems, prevalence and approaches to therapy,” in: Brain Diseases: Innovatory Approaches to Diagnosis and Treatment, Gusev, E. I. and Guekht, A. B. (eds.), Sam Poligrafist, Moscow (2022).

  35. Hass, D. R. G., Muraroto, E., Von Der Heyde, M., and Skare, T. L., “Prevalence of fibromyalgia in depressive patients and its influence in the degree of depression and quality of life,” Asia Pac. Psychiatry, 6, No. 4, 458–459 (2014), https://doi.org/10.1111/APPY.12159.

    Article  PubMed  Google Scholar 

  36. Henao-Pérez, M., López-Medina, D. C., Arboleda, A., et al., “Patients with fibromyalgia, depression, and/or anxiety and sex differences,” Am. J. Mens Health, 16, No. 4, 15579883221110351 (2022), https://doi.org/10.1177/15579883221110351.

  37. Minhas, D., Murphy, A., and Clauw, D. J., “Fibromyalgia and centralized pain in the rheumatoid arthritis patient,” Curr. Opin. Rheumatol., 35, No. 3, 170–174 (2023), https://doi.org/10.1097/BOR.0000000000000929.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Walitt, B., Nahin, R. L., Katz, R. S., et al., “The prevalence and characteristics of fibromyalgia in the 2012 National Health Interview Survey,” PLoS One, 10, No. 9, e0138024 (2015), https://doi.org/10.1371/JOURNAL.PONE.0138024.

    Article  Google Scholar 

  39. Clauw, D. J., “Fibromyalgia: a clinical review,” JAMA, 311, No. 15, 1547–1555 (2014), https://doi.org/10.1001/JAMA.2014.3266.

    Article  PubMed  Google Scholar 

  40. Winfield, J. B., “Pain in fibromyalgia,” Rheum. Dis. Clin. North Am,. 25, No. 1, 55–79 (1999).

    Article  CAS  PubMed  Google Scholar 

  41. Bennett, R. M., Jones, J., Turk, D. C., et al., “An internet survey of 2,596 people with fibromyalgia,” BMC Musculoskelet. Disord., 8, 27 (2007), https://doi.org/10.1186/1471-2474-8-27.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Ohayon, M. M., “Prevalence and correlates of nonrestorative sleep complaints,” Arch. Int. Med., 165, No. 1, 35–41 (2005), https://doi.org/10.1001/ARCHINTE.165.1.35.

    Article  Google Scholar 

  43. Choy, E. H. S., “The role of sleep in pain and fibromyalgia,” Nat. Rev. Rheumatol., 11, No. 9, 513–520 (2015), https://doi.org/10.1038/NRRHEUM.2015.56.

    Article  PubMed  Google Scholar 

  44. Roizenblatt, S., Neto, N. S. R., and Tufik, S., “Sleep disorders and fibromyalgia,” Curr. Pain Headache Rep., 15, No. 5, 347–357 (2011), https://doi.org/10.1007/S11916-011-0213-3.

    Article  PubMed  Google Scholar 

  45. Catalá, P., Gutiérrez, L., Écija, C., and Peñacoba, C., “Pathological cycle between pain, insomnia, and anxiety in women with fibromyalgia and its association with disease impact,” Biomedicines, 11, No. 1, 148 (2023), https://doi.org/10.3390/BIOMEDICINES11010148.

    Article  Google Scholar 

  46. Husak, A. J. and Bair, M. J., “Chronic pain and sleep disturbances: A pragmatic review of their relationships, comorbidities, and treatments,” Pain Med., 21, No. 6, 1142–1152 (2020), https://doi.org/10.1093/PM/PNZ343.

    Article  PubMed  Google Scholar 

  47. Moore, D. J., Keogh, E., and Eccleston, C., “The interruptive effect of pain on attention,” Q. J. Exp. Psychological. (Hove), 65, No. 3, 565–586 (2012), https://doi.org/10.1080/17470218.2011.626865.

    Article  Google Scholar 

  48. Elkana, O., Falcofsky, A. K., Shorer, R., et al., “Does the cognitive index of the symptom severity scale evaluate cognition? Data from subjective and objective cognitive measures in fibromyalgia,” Clin. Exp. Rheumatol., 37, No. 1, supplement 116, 51–57 (2019).

  49. Estévez-López, F., Álvarez-Gallardo, I. C., Segura-Jiménez, V., et al., “The discordance between subjectively and objectively measured physical function in women with fibromyalgia: association with catastrophizing and self-efficacy cognitions. The al-Ándalus project,” Disabil. Rehabil., 40, No. 3, 329–337 (2018), https://doi.org/10.1080/09638288.2016.1258737.

    Article  PubMed  Google Scholar 

  50. Walitt, B., Čeko, M., Khatiwada, M., et al., “Characterizing ‘fibrofog’: Subjective appraisal, objective performance, and task-related brain activity during a working memory task,” NeuroImage Clin., 11, 173–180 (2016), https://doi.org/10.1016/J.NICL.2016.01.021.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Huang, I. C., Lee, J. L., Ketheeswaran, P., et al., “Does personality affect health-related quality of life? A systematic review,” PLoS One, 12, No. 3, e0173806 (2017), https://doi.org/10.1371/JOURNAL.PONE.0173806.

    Article  Google Scholar 

  52. Carta, M. G., Moro, M. F., Pinna, F. L., et al., “The impact of fibromyalgia syndrome and the role of comorbidity with mood and post-traumatic stress disorder in worsening the quality of life,” Int. J. Soc. Psychiatry, 64, No. 7, 647–655 (2018), https://doi.org/10.1177/0020764018795211.

    Article  PubMed  Google Scholar 

  53. Offenbaecher, M., Kohls, N., Ewert, T., et al., “Pain is not the major determinant of quality of life in fibromyalgia: results from a retrospective «real world» data analysis of fibromyalgia patients,” Rheumatol. Int., 41, No. 11, 1995–2006 (2021), https://doi.org/10.1007/S00296-020-04702-5.

    Article  PubMed  Google Scholar 

  54. Attademo, L. and Bernardini, F., “Prevalence of personality disorders in patients with fibromyalgia: a brief review,” Prim Health Care Res Dev, 19, No. 5, 523–528 (2017), https://doi.org/10.1017/S1463423617000871.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Nasonova, T. I., Romanov, D. V., Mukhametzyanova, A. Kh., et al., “Mental disorders in patients with fibromyalgia: psychometric assessment of anxiety, depression, somatization, and personality disorders,” Ross. Zh. Boli, 20, No. 3, 21–26 (2022), https://doi.org/10.17116/PAIN20222003121.

  56. Fu, T., Gamble, H., Siddiqui, U., and Schwartz, T. L., “Psychiatric and personality disorder survey of patients with fibromyalgia,” Ann. Depress. Anxiety, 2, No. 6, 1064 (2015).

  57. Marchi, L., Marzetti, F., Orrù, G., et al., “Alexithymia and psychological distress in patients with fibromyalgia and rheumatic disease,” Front. Psychol., 10, 1735 (2019), https://doi.org/10.3389/fpsyg.2019.01735.

    Article  PubMed  PubMed Central  Google Scholar 

  58. van Middendorp, H., Kool, M. B., van Beugen, S., et al., “Prevalence and relevance of Type D personality in fibromyalgia,” Gen. Hosp. Psychiatry, 39, 66–72 (2016), https://doi.org/10.1016/J.GENHOSPPSYCH.2015.11.006.

    Article  PubMed  Google Scholar 

  59. Montoro, C. I. and Reyes del Paso, G. A., “Personality and fibromyalgia: Relationships with clinical, emotional, and functional variables,” Personal. Individ. Differ., 85, 236–244 (2015), https://doi.org/10.1016/J.PAID.2015.05.017.

  60. Goodwin, R. D. and Friedman, H. S., “Health status and the five-factor personality traits in a nationally representative sample,” J. Health Psychol., 11, No. 5, 643–654 (2006), https://doi.org/10.1177/1359105306066610.

    Article  PubMed  Google Scholar 

  61. Torres, X., Bailles, E., Valdes, M., et al., “Personality does not distinguish people with fibromyalgia but identifies subgroups of patients,” Gen. Hosp. Psychiatry, 35, No. 6, 640–648 (2013), https://doi.org/10.1016/J.GENHOSPPSYCH.2013.07.014.

    Article  PubMed  Google Scholar 

  62. Alciati, A., Sgiarovello, P., Atzeni, F., and Sarzi-Puttini, P., “Psychiatric problems in fibromyalgia: clinical and neurobiological links between mood disorders and fibromyalgia,” Reumatismo, 64, No. 4, 268–274 (2012).

    Article  CAS  PubMed  Google Scholar 

  63. Løge-Hagen, J. S., Sæle, A., Juhl, C., et al., “Prevalence of depressive disorder among patients with fibromyalgia: Systematic review and meta-analysis,” J. Affect. Disord., 245, 1098–1105 (2019), https://doi.org/10.1016/J.JAD.2018.12.001.

    Article  PubMed  Google Scholar 

  64. Åsbring, P. and Närvänen, A. L., “Women’s experiences of stigma in relation to chronic fatigue syndrome and fibromyalgia,” Qual. Health Res., 12, No. 2, 148–160 (2002), https://doi.org/10.1177/104973230201200202.

    Article  PubMed  Google Scholar 

  65. Hasselroth, R., Björling, G., Faag, C., and Bose, C. N., “Can someone as young as you really feel that much pain? – A survey on how people with fibromyalgia experience healthcare in Sweden,” SAGE Open Nurs., 7, 23779608211026145 (2021), https://doi.org/10.1177/23779608211026145.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Fuller-Thomson, E., Nimigon-Young, J., and Brennenstuhl, S., “Individuals with fibromyalgia and depression: findings from a nationally representative Canadian survey,” Rheumatol. Int., 32, No. 4, 853–862 (2012), https://doi.org/10.1007/S00296-010-1713-X.

    Article  PubMed  Google Scholar 

  67. Sauch Valmaña, G., Miró Catalina, Q., Carrasco-Querol, N., and Vidal-Alaball, J., “Gender, mental health and socioeconomic differences in fibromyalgia: A retrospective cohort study using real-world data from Catalonia,” Healthcare (Basel), 11, No. 4, 530 (2023), https://doi.org/10.3390/healthcare11040530.

    Article  Google Scholar 

  68. Levine, D. and Horesh, D., “Suicidality in fibromyalgia: A systematic review of the literature,” Front. Psychiatry, 11, 535368 (2020), https://doi.org/10.3389/fpsyt.2020.535368.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Liu, H. Y., Fuh, J. L., et al., “Suicide risk in patients with migraine and comorbid fibromyalgia,” Neurology, 85, No. 12, 1017–1023 (2015), https://doi.org/10.1212/WNL.0000000000001943.

    Article  CAS  PubMed  Google Scholar 

  70. Triñanes, Y., González-Villar, A., Gómez-Perretta, C., and Carrillo-de-la-Peña, M. T., “Suicidality in chronic pain: predictors of suicidal ideation in fibromyalgia,” Pain Pract., 15, No. 4, 323–332 (2015), https://doi.org/10.1111/PAPR.12186.

    Article  PubMed  Google Scholar 

  71. Boring, B. L., Walsh, K. T., Nanavaty, N., and Mathur, V. A., “Shame mediates the relationship between pain invalidation and depression,” Front. Psychol., 12, 743584 (2021), https://doi.org/10.3389/FPSYG.2021.743584.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Ross, R. L., Jones, K. D., Ward, R. L., et al., “Atypical depression is more common than melancholic in fibromyalgia: an observational cohort study,” BMC Musculoskelet. Disord., 11, 120 (2010), https://doi.org/10.1186/1471-2474-11-120.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Kudlow, P. A., Rosenblat, J. D., Weissman, C. R., et al., “Prevalence of fibromyalgia and co-morbid bipolar disorder: A systematic review and meta-analysis,” J. Affect. Disord., 188, 134–142 (2015), https://doi.org/10.1016/j.jad.2015.08.030.

    Article  CAS  PubMed  Google Scholar 

  74. Bortolato, B., Berk, M., Maes, M., et al., “Fibromyalgia and bipolar disorder: Emerging epidemiological associations and shared pathophysiology,” Curr. Mol. Med., 16, No. 2, 119–136 (2016), https://doi.org/10.2174/1566524016666160126144027.

    Article  CAS  PubMed  Google Scholar 

  75. Maletic, V. and Raison, C. L., “Neurobiology of depression, fibromyalgia and neuropathic pain,” Front. Biosci., 14, No. 14, 5291– 5338 (2009), https://doi.org/10.2741/3598.

    Article  CAS  Google Scholar 

  76. Köteles, F. and Witthöft, M., “Somatosensory amplification – An old construct from a new perspective,” J. Psychosom. Res., 101, 1–9 (2017), https://doi.org/10.1016/J.JPSYCHORES.2017.07.011.

    Article  PubMed  Google Scholar 

  77. Clark, J. R., Nijs, J., Yeowell, G., et al., “Trait sensitivity, anxiety, and personality are predictive of central sensitization symptoms in patients with chronic low back pain,” Pain Pract., 19, No. 8, 800– 810 (2019), https://doi.org/10.1111/PAPR.12809.

    Article  PubMed  Google Scholar 

  78. Gunnarsson, H., Safipour, J., Elmqvist, C., and Lindqvist, G., “Different pain variables could independently predict anxiety and depression in subjects with chronic musculoskeletal pain,” Scand. J. Pain, 21, No. 2, 274–282 (2021), https://doi.org/10.1515/SJPAIN-2020-0129.

    Article  PubMed  Google Scholar 

  79. Leeuw, M., Goossens, M. E. J. B., Linton, S. J., et al., “The fear-avoidance model of musculoskeletal pain: current state of scientific evidence,” J. Behav. Med., 30, No. 1, 77–94 (2007), https://doi.org/10.1007/S10865-006-9085-0.

    Article  PubMed  Google Scholar 

  80. Crombez, G., Vlaeyen, J. W. S., Heuts PHTG, and Lysens, R., “Painrelated fear is more disabling than pain itself: evidence on the role of pain-related fear in chronic back pain disability,” Pain, 80, No. 1–2, 329–339 (1999), https://doi.org/10.1016/S0304-3959(98)00229-2.

    Article  CAS  PubMed  Google Scholar 

  81. Häuser, W., Galek, A., Erbslöh-Möller, B., et al., “Posttraumatic stress disorder in fibromyalgia syndrome: prevalence, temporal relationship between posttraumatic stress and fibromyalgia symptoms, and impact on clinical outcome,” Pain, 154, No. 8, 1216–1223 (2013), https://doi.org/10.1016/J.PAIN.2013.03.034.

    Article  PubMed  Google Scholar 

  82. Miró, E., Martínez, M. P., Sánchez, A. I., and Cáliz, R., “Clinical manifestations of trauma exposure in fibromyalgia: The role of anxiety in the association between posttraumatic stress symptoms and fibromyalgia status,” J. Trauma. Stress, 33, No. 6, 1082–1092 (2020), https://doi.org/10.1002/JTS.22550.

    Article  PubMed  Google Scholar 

  83. Avishai Cohen, H. and Zerach, G., “Associations between posttraumatic stress symptoms, anxiety sensitivity, socially prescribed perfectionism, and severity of somatic symptoms among individuals with fibromyalgia,” Pain Med., 22, No. 2, 363–371 (2021), https://doi.org/10.1093/PM/PNAA327.

    Article  PubMed  Google Scholar 

  84. Mousa, R. F., Al-Hakeim, H. K., Alhaideri, A., and Maes, M., “Chronic fatigue syndrome and fibromyalgia-like symptoms are an integral component of the phenome of schizophrenia: neuro-immune and opioid system correlates,” Metab. Brain. Dis., 36, No. 1, 169–183 (2021), https://doi.org/10.1007/S11011-020-00619-X.

    Article  CAS  PubMed  Google Scholar 

  85. Almulla, A. F., Al-Hakeim, H. K., Abed, M. S., et al., “Chronic fatigue and fibromyalgia symptoms are key components of deficit schizophrenia and are strongly associated with activated immune-inflammatory pathways,” Schizophr. Res., 222, 342–353 (2020), https://doi.org/10.1016/J.SCHRES.2020.05.003.

    Article  PubMed  Google Scholar 

  86. Häuser, W., Kosseva, M., Üceyler, N., et al., “Emotional, physical, and sexual abuse in fibromyalgia syndrome: a systematic review with meta-analysis,” Arthritis Care Res., 63, No. 6, 808–820 (2011), https://doi.org/10.1002/ACR.20328.

    Article  Google Scholar 

  87. Häuser, W., Hoffmann, E. M., Wolfe, F., et al., “Self-reported childhood maltreatment, lifelong traumatic events and mental disorders in fibromyalgia syndrome: a comparison of US and German outpatients,” Clin. Exp. Rheumatol., 33, No. 10, S86 (2015).

  88. Wilson, D. R., “Health consequences of childhood sexual abuse,” Perspect. Psychiatr. Care, 46, No. 1, 56–64 (2010), https://doi.org/10.1111/J.1744-6163.2009.00238.X.

    Article  PubMed  Google Scholar 

  89. Jensen, K. B., Srinivasan, P., Spaeth, R., et al., “Overlapping structural and functional brain changes in patients with long-term exposure to fibromyalgia pain,” Arthritis Rheum., 65, No. 12, 3293–3303 (2013), https://doi.org/10.1002/ART.38170.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Schmidt-Wilcke, T., Luerding, R., Weigand, T., et al., “Striatal grey matter increase in patients suffering from fibromyalgia – a voxel-based morphometry study,” Pain, 132, Suppl. 1, 109–116 (2007), https://doi.org/10.1016/J.PAIN.2007.05.010.

    Article  Google Scholar 

  91. Gracely, R. H., Geisser, M. E., Giesecke, T., et al., “Pain catastrophizing and neural responses to pain among persons with fibromyalgia,” Brain, 127, No. Pt 4, 835–843 (2004), https://doi.org/10.1093/BRAIN/AWH098.

    Article  CAS  PubMed  Google Scholar 

  92. McLoughlin, M. J., Stegner, A. J., and Cook, D. B., “The relationship between physical activity and brain responses to pain in fibromyalgia,” J. Pain, 12, No. 6, 640–651 (2011), https://doi.org/10.1016/J.JPAIN.2010.12.004.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Ellingson, L. D., Shields, M. R., Stegner, A. J., and Cook, D. B., “Physical activity, sustained sedentary behavior, and pain modulation in women with fibromyalgia,” J. Pain, 13, No. 2, 195–206 (2012), https://doi.org/10.1016/J.JPAIN.2011.11.001.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Craggs, J. G., Staud, R., Robinson, M. E., et al., “Effective connectivity among brain regions associated with slow temporal summation of C-fiber-evoked pain in fibromyalgia patients and healthy controls,” J. Pain, 13, No. 4, 390–400 (2012), https://doi.org/10.1016/J.JPAIN.2012.01.002.

    Article  PubMed  PubMed Central  Google Scholar 

  95. Hagelberg, N., Jääskeläinen, S. K., Martikainen, I. K., et al., “Striatal dopamine D2 receptors in modulation of pain in humans: a review,” Eur. J. Pharmacol., 500, No. 1–3, 187–192 (2004), https://doi.org/10.1016/J.EJPHAR.2004.07.024.

    Article  CAS  PubMed  Google Scholar 

  96. Loggia, M. L., Berna, C., Kim, J., et al., “Disrupted brain circuitry for pain-related reward/punishment in fibromyalgia,” Arthritis Rheumatol., 66, No. 1, 203–212 (2014), https://doi.org/10.1002/ART.38191.

    Article  PubMed  PubMed Central  Google Scholar 

  97. Harris, R. E., Gracely, R. H., McLean, S. A., et al., “Comparison of clinical and evoked pain measures in fibromyalgia,” J. Pain, 7, No. 7, 521–527 (2006), https://doi.org/10.1016/J.JPAIN.2006.01.455.

    Article  PubMed  Google Scholar 

  98. Lieb, K., Treffurth, Y., Berger, M., and Fiebich, B. L., “Substance P and affective disorders: new treatment opportunities by neurokinin 1 receptor antagonists?” Neuropsychobiology, 45. Supl. 1, 2–6 (2002), https://doi.org/10.1159/000049254.

    Article  Google Scholar 

  99. Harris, R. E., Napadow, V., Huggins, J. P., et al., “Pregabalin rectifies aberrant brain chemistry, connectivity, and functional response in chronic pain patients,” Anesthesiology, 119, No. 6, 1453–1464 (2013), https://doi.org/10.1097/ALN.0000000000000017.

    Article  CAS  PubMed  Google Scholar 

  100. Diers, M., Yilmaz, P., Rance, M., et al., “Treatment-related changes in brain activation in patients with fibromyalgia syndrome,” Exp. Brain Res., 218, No. 4, 619–628 (2012), https://doi.org/10.1007/S00221-012-3055-2.

    Article  CAS  PubMed  Google Scholar 

  101. Napadow, V., Kim, J., Clauw, D. J., and Harris, R. E., “Decreased intrinsic brain connectivity is associated with reduced clinical pain in fibromyalgia,” Arthritis Rheum., 64, No. 7, 2398–2403 (2012), https://doi.org/10.1002/ART.34412.

    Article  PubMed  PubMed Central  Google Scholar 

  102. Tanriverdi, F., Karaca, Z., Unluhizarci, K., and Kelestimur, F., “The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome,” Stress, 10, No. 1, 13–25 (2007), https://doi.org/10.1080/10253890601130823.

    Article  CAS  PubMed  Google Scholar 

  103. Gold, P. W., Gabry, K. E., Yasuda, M. R., and Chrousos, G. P., “Divergent endocrine abnormalities in melancholic and atypical depression: clinical and pathophysiologic implications,” Endocrinol. Metab. Clin. North Am., 31, No. 1, 37–62 (2002), https://doi.org/10.1016/S0889-8529(01)00022-6.

    Article  CAS  PubMed  Google Scholar 

  104. Kato, K., Sullivan, P. F., Evengård, B., and Pedersen, N. L., “Importance of genetic influences on chronic widespread pain,” Arthritis Rheum., 54, No. 5, 1682–1686 (2006), https://doi.org/10.1002/ART.21798.

    Article  CAS  PubMed  Google Scholar 

  105. Buskila, D., Cohen, H., Neuman, L., and Ebstein, R. P., “An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits,” Mol. Psychiatry, 9, No. 8, 730–731+727 (2004), https://doi.org/10.1038/SJ.MP.4001506.

  106. Ablin, J. N., Cohen, H., and Buskila, D., “Mechanisms of disease: genetics of fibromyalgia,” Nat. Clin. Pract. Rheumatol., 2, No. 12, 671–678 (2006), https://doi.org/10.1038/NCPRHEUM0349.

    Article  CAS  PubMed  Google Scholar 

  107. Goldenberg, D. L., Clauw, D. J., Palmer, R. E., and Clair, A. G., “Opioid use in fibromyalgia: A cautionary tale,” Mayo Clin. Proc., 91, No. 5, 640–648 (2016), https://doi.org/10.1016/J.MAYOCP.2016.02.002.

    Article  CAS  PubMed  Google Scholar 

  108. Munblit, D., Bobkova, P., Spiridonova, E., et al., “Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19,” Clin. Exp. Allergy, 51, No. 9, 1107–1120 (2021), https://doi.org/10.1111/CEA.13997.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  109. Beghi, E., Giussani, G., Westenberg, E., et al., “Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions,” J. Neurol., 269, No. 5, 2265–2274 (2022), https://doi.org/10.1007/S00415-021-10848-4.

    Article  CAS  PubMed  Google Scholar 

  110. Fialho, M. F. P., Brum, E. S., and Oliveira, S. M., “Could the fibromyalgia syndrome be triggered or enhanced by COVID-19?” Inflammopharmacology, 31, No. 2, 633–651 (2023), https://doi.org/10.1007/S10787-023-01160-W.

    Article  PubMed  PubMed Central  Google Scholar 

  111. Macfarlane, G. J., Kronisch, C., Dean, L. E., et al., “EULAR revised recommendations for the management of fibromyalgia,” Ann. Rheum. Dis., 76, No. 2, 318–328 (2017), https://doi.org/10.1136/ANNRHEUMDIS-2016-209724.

    Article  CAS  PubMed  Google Scholar 

  112. Üçeyler, N., Sommer, C., Walitt, B., and Häuser, W., “Anticonvulsants for fibromyalgia,” Cochrane Database Syst. Rev., 10, CD010782 (2013), https://doi.org/10.1002/14651858.CD010782.

  113. Häuser, W., Urrútia, G., Tort, S., et al., “Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome,” Cochrane Database Syst. Rev., 1, CD010292 (2013), https://doi.org/10.1002/14651858.CD010292.

  114. Kia, S. and Choy, E., “Update on treatment guideline in fibromyalgia syndrome with focus on pharmacology,” Biomedicines, 5, No. 2, 20 (2017), https://doi.org/10.3390/BIOMEDICINES5020020.

    Article  Google Scholar 

  115. Lloyd, D. M., Wittkopf, P. G., Arendsen, L. J., and Jones, A. K. P., “Is transcranial direct current stimulation (tDCS) effective for the treatment of pain in fibromyalgia? A systematic review and meta-analysis,” J. Pain, 21, No. 11–12, 1085–1100 (2020), https://doi.org/10.1016/J.JPAIN.2020.01.003.

    Article  PubMed  Google Scholar 

  116. Lefaucheur, J. P., Aleman, A., Baeken, C., et al., “Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS, An update (2014–2018),” Clin. Neurophysiol., 131, No. 2, 474–528 (2020), https://doi.org/10.1016/J.CLINPH.2019.11.002.

    Article  PubMed  Google Scholar 

  117. Su, Y. C., Guo, Y. H., Hsieh, P. C., and Lin, Y. C., “Efficacy of repetitive transcranial magnetic stimulation in fibromyalgia: A systematic review and meta-analysis of randomized controlled trials,” J. Clin. Med., 10, No. 20, 4669 (2021), https://doi.org/10.3390/JCM10204669.

  118. Aman, M. M., Jason Yong, R., Kaye, A. D., and Urman, R. D., “Evidence-based non-pharmacological therapies for fibromyalgia,” Curr. Pain Headache Rep., 22, No. 5, 33 (2018), https://doi.org/10.1007/S11916-018-0688-2.

Download references

Author information

Authors and Affiliations

  1. Solovyev Scientific and Applied Psychoneurology Center, Moscow Health Department, Moscow, Russia

    M. S. Zinchuk, A. M. Turchinets, D. A. Tumurov, D. V. Zhuravlev, J. E. Bryzgalova & A. B. Guekht

  2. Pirogov Russian National Research Medical University, Russian Ministry of Health, Moscow, Russia

    A. B. Guekht

Authors
  1. M. S. Zinchuk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. M. Turchinets
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. A. Tumurov
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. V. Zhuravlev
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. E. Bryzgalova
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. B. Guekht
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. S. Zinchuk.

Additional information

Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 123, No. 10, pp 7–16, October, 2023.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zinchuk, M.S., Turchinets, A.M., Tumurov, D.A. et al. Current Views on the Relationship between Fibromyalgia and Mental Disorders. Neurosci Behav Physi 54, 388–397 (2024). https://doi.org/10.1007/s11055-024-01603-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11055-024-01603-z

Keywords

Search

Navigation